Release Date: 30/10/09 18:17 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 185.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%